 | PMV Pharmaceuticals, Inc. | |||
| NMS : PMVP || Location: United States | ||||
$1.690.0 (0.0%) |
0.2 M | 1.65 - 1.72 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.601 M |
| March 15, 2024 | 2.258 M |
| Feb. 29, 2024 | 1.983 M |
| Feb. 15, 2024 | 1.841 M |
| Jan. 31, 2024 | 1.747 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.39 | -0.31 | 21.26% |
| 09/30/2023 | -0.45 | -0.34 | 25.26% |
| 06/30/2023 | -0.48 | -0.38 | 21.57% |
| 03/31/2023 | -0.47 | -0.42 | 10.16% |
| 12/31/2022 | -0.45 | -0.43 | 3.82% |
PMVP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 51.444M | Shares Float | 41.007M |
| Short Float | 2.601M | Market Cap | 86.94M |
| Institution ownership | 0.00% | Insider ownership | 2.946% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.44 | Forward EPS | -1.42 |